P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 13; no. 10; pp. S536 - S537
Main Authors Martinez Moreno, E., Irigoyen Medina, A., Alvarez Cabellos, R., Martinez, K.A., Santiago, J., Rivilla, M., Cardenas, J.D., Esteban, C., Trujillo, B., Rosero, A., Fernandez, L., Ramos, I., Ramos, A., Chacon, J.I.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2018.08.744